Health knowledge made personal
Join this community!
› Share page:
Search posts:

Women’s Infertility - Drug Pipeline Analysis and Market Forecasts to 2016-

Posted May 19 2010 2:01am

The industry analysis specialist’s new report, “Women’s Infertility – Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global women’s infertility market. The report identifies the key trends shaping and driving the global women’s Infertility market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global women’s infertility sector. 


This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by   team of industry experts.



The report analyzes the opportunities and challenges for the global women’s infertility disease market. It includes


  - Annualized global women’s infertility disease market revenues data from 2001 to 2009, forecast for seven years to 2016.

  - Geographic markets covered in this report are the US, the UK, Italy, Spain, Germany, France, and Japan.

  - Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include GnRH antagonists, AMP-activated protein kinase (AMPK) agonists, luteinising hormone stimulators and Beta 2 receptor agonists.

  - Analysis of the current and future competitors in the global women’s infertility market. The key market players covered are Merck Serono SA, Ferring Pharmaceuticals, Dong-A Pharmaceutical Co., Ltd. and PregLem SA.

  - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

  - The key topics covered include a strategic competitor assessment, market characterization, unmet needs and implications for the future women’s infertility market.  


The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:


  - Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

  - Develop business strategies by understanding the trends shaping and driving the global women’s infertility market.

  - Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global women’s infertility market in future.

  - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

  - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

  - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

  - What’s the next big thing in the global women’s infertility market landscape? – Identify, understand and capitalize

More Information Click Here:’s-Infertility-Drug-Pipeline-Analysis-and-

Post a comment
Write a comment:

Related Searches